NeuroSense Therapeutics
(NASDAQ:NRSN)
$1.43
0.07[5.15%]
At close: Apr 24
$1.43
0[0.00%]
After Hours: 8:12AM EDT
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

NeuroSense Therapeutics Stock (NASDAQ:NRSN), Quotes and News Summary

NeuroSense Therapeutics Stock (NASDAQ: NRSN) stock price, news, charts, stock research, profile.

Open$1.420
Close$1.340
Volume / Avg.132.972K / 310.717K
Day Range1.300 - 1.500
52 Wk Range0.400 - 2.330
Market Cap$24.788M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
37
Short Interest
0.45%
Days to Cover1

Recent News

Sponsored
NeuroSense's (NASDAQ: NRSN) ALS Drug Candidate Shows Promise In Recent Phase 2b Trial; More Milestones To Come In 2024
Amyotrophic lateral sclerosis (ALS) is a progressive neurological disease that kills the nerve cells controlling the voluntary movement of muscles. It is incurable and results in complete paralysis and ultimately death within two to five years from diagnosis. Each year, about 5,000 people in the U.S.
Why AeroVironment Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of AeroVironment, Inc. (NASDAQ: AVAV) moved lower during Wednesday’s session following second-quarter results.
Lisa Levin
US Stocks Higher; Private Payrolls Rise By 103,000 In November
U.S. stocks traded higher this morning, following the release of economic reports on Wednesday. Following the market opening Wednesday, the Dow traded up 0.21% to 36,200.86 while the NASDAQ rose 0.28% to 14,270.30. The S&P 500 also rose, gaining, 0.32% to 4,581.88.
Lisa Levin
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Rating
12345
4.0
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About
Sector
Healthcare
Industry
N/A
NeuroSense Therapeutics Ltd is a clinical-stage biotechnology company focused on discovering and dev...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
NRSN

FAQ

Q

How do I buy NeuroSense Therapeutics (NRSN) stock?

A

You can purchase shares of NeuroSense Therapeutics (NASDAQ: NRSN) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are NeuroSense Therapeutics's (NRSN) competitors?

A

There are no as such competitors for NeuroSense Therapeutics.

Q

What is the target price for NeuroSense Therapeutics (NRSN) stock?

A

The latest price target for NeuroSense Therapeutics (NASDAQ: NRSN) was reported by Alliance Global Partners on Monday, July 17, 2023. The analyst firm set a price target for 7.50 expecting NRSN to rise to within 12 months (a possible 424.48% upside). 1 analyst firms have reported ratings in the last year.

Q

Current Stock Price for NeuroSense Therapeutics (NRSN)?

A

The stock price for NeuroSense Therapeutics (NASDAQ: NRSN) is $1.43 last updated April 24, 2024 at 8:12 AM EDT.

Q

Does NeuroSense Therapeutics (NRSN) pay a dividend?

A

There are no upcoming dividends for NeuroSense Therapeutics.

Q

When is NeuroSense Therapeutics (NASDAQ:NRSN) reporting earnings?

A

NeuroSense Therapeutics’s Q1 earnings are confirmed for Thursday, May 30, 2024.

Q

Is NeuroSense Therapeutics (NRSN) going to split?

A

There is no upcoming split for NeuroSense Therapeutics.

Q

What sector and industry does NeuroSense Therapeutics (NRSN) operate in?

A

NeuroSense Therapeutics is in the Healthcare sector and Biotechnology industry. They are listed on the NASDAQ.